CPC
GILD icon

Consolidated Planning Corp’s Gilead Sciences GILD Stock Holding History

Consolidated Planning Corp’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$272K Hold
1,949
– – 0.04% 125
2025
Q4 		$239K Hold
1,949
– – 0.02% 191
2025
Q3 		$216K Buy
1,949
+98
+5% +$11.1K 0.02% 182
2025
Q2 		$205K Hold
1,851
– – 0.03% 182
2025
Q1 		$207K Buy
+1,851
New +$191K 0.03% 178
2021
Q4 		– Sell
-51
Closed -$4K – 211
2021
Q3 		$4K Buy
+51
New +$3.58K ﹤0.01% 375

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Consolidated Planning Corp's GILD Position: Q1 2026 in Review

Consolidated Planning Corp held its Gilead Sciences (GILD) position steady in Q1 2026 at 1,949 shares worth $272K. The position accounts for 0.04% of the portfolio, ranked #125.

Consolidated Planning Corp first reported a position in GILD in Q3 2021 and has held it in 6 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Consolidated Planning Corp held 1,949 shares of Gilead Sciences worth $272K as of Q1 2026.
  • Consolidated Planning Corp left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.04% of Consolidated Planning Corp's portfolio in Q1 2026, its #125 holding.
  • Consolidated Planning Corp first reported a position in Gilead Sciences in Q3 2021 and has held it in 6 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Consolidated Planning Corp's 13F filing for Q1 2026, filed 16 Apr 2026.